Cutaneous Leishmaniasis Due to Leishmania infantum
1998/02/01 by P. Del Giudice, Pascal del Giudice, Pierre Marty +10 · 24 citations
Medicine · #Research on Leishmaniasis Studies #Eosinophilic Disorders and Syndromes #Chronic Myeloid Leukemia Treatments
paper · doi:10.1001/archderm.134.2.193
Abstract
BACKGROUND: Leishmania infantum recently has been identified as a possible agent of cutaneous leishmaniasis (CL). This species has been isolated from cutaneous lesions of patients from the Mediterranean Basin. However, little is known about the clinical, biological, or therapeutic features of this newly recognized CL. OBSERVATIONS: Six patients aged 9 months to 85 years in southeastern France were found to have autochthonous leishmaniasis. Parasitological identification showed that the agent was L infantum, zymodemes Montpellier-1 for 2 patients and Montpellier-24 for 1 patient. Five patients who underwent testing with a Western blot assay were found to have antibodies against 4 antigens with molecular masses of 18, 21, 23, and 31 kd. Five patients were successfully treated with local injections of N-methylglucamine, and 1 patient was successfully treated with topical paromomycin sulfate. No patient had visceral disease at diagnosis or after follow-up. CONCLUSIONS: Recent data provide increasing evidence that L infantum is an important agent of CL. In southwestern Europe, this species is the only agent that has long been identified from autochthonous CL. Leishmania infantum should be considered an agent of CL in areas in which visceral leishmaniasis is endemic. Western blot assay could be a useful test for the diagnosis, but precise parasitological identification is important to having a better knowledge of the disease. The relationships between CL and the visceral disease have to be explored.
Cited by
- Non-healing old world cutaneous leishmaniasis caused by L. infantum in a patient from Spain. [europepmc]
- A case of imported Leishmania infantum cutaneous leishmaniasis; an unusual presentation occurring 19 years after travel. [europepmc]
- Cutaneous leishmaniasis in the central provinces of Hama and Edlib in Syria: Vector identification and parasite typing. [europepmc]
- Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy. [europepmc]
- Evaluation of Regulatory Immune Response in Skin Lesions of Patients Affected by Nonulcerated or Atypical Cutaneous Leishmaniasis in Honduras, Central America. [europepmc]
- Place of Serology in the Diagnosis of Zoonotic Leishmaniases With a Focus on Visceral Leishmaniasis Due to Leishmania infantum . [europepmc]
- One Health Approach to Leishmaniases: Understanding the Disease Dynamics through Diagnostic Tools. [europepmc]
- In situ cellular immune response in non-ulcerated skin lesions due to Leishmania (L.) infantum chagasi infection. [europepmc]
- The Geographical Distribution of Human Cutaneous and Visceral Leishmania Species Identified by Molecular Methods in Iran: A Systematic Review With Meta-Analysis. [europepmc]
- Canine and Feline Parasitology: Analogies, Differences, and Relevance for Human Health. [europepmc]
- Unusual Observations in Leishmaniasis-An Overview. [europepmc]
- Cutaneous Leishmaniasis Caused by Leishmania infantum, Israel, 2018-2021. [europepmc]
- A Rare Case of Imported Cutaneous Leishmaniasis Caused by Leishmania infantum in the Republic of Korea, 2021. [europepmc]
- Clinical and immunological spectra of human cutaneous leishmaniasis in North Africa and French Guiana. [europepmc]
- Diagnostic Tools for Cutaneous Leishmaniasis Caused by Leishmania donovani : A Narrative Review. [europepmc]
- [Complex cutaneous leishmaniasis with bone involvement]. [europepmc]
- Isolation and characterisation of Leishmania (Leishmania) infantum from cutaneous leishmaniasis patients in northeast Brazil. [europepmc]
- The Epidemiology of PCR-Confirmed Cutaneous Leishmaniasis in Israel: A Nationwide Study. [europepmc]
- Molecular Insights into Cell-Mediated Immunity in Atypical Non-Ulcerated Cutaneous Leishmaniasis. [europepmc]
- Evaluation of the Antileishmanial Activity of Some Benzimidazole Derivatives Using In Vitro and In Silico Techniques. [europepmc]
- A Century of Epidemiological Advances in Cutaneous and Visceral Leishmaniasis in Algeria. [europepmc]
- Autochthonous Leishmaniasis in the United States of America. [europepmc]
- Leishmaniasis in Morocco: Epidemiology, Transmission Dynamics, and the Potential of Artificial Intelligence for Disease Management. [europepmc]
- Clinical, laboratory, and therapeutic characteristics of cutaneous leishmaniasis: 15-year incidence in Crete and Greece, and implications for clinician awareness. [europepmc]
Related